I+D

I+D

I+D (2)

I+D (2)

I+D (3)

I+D (3)

I+D (4)

I+D (4)

ICTUS

PHARMACEUTICAL DEVELOPMENT OF DESIGN LIPIDS FOR THE TREATMENT OF ICTUS AND RELATED PATHOLOGIES


In our country, millions of people die every year as a consequence of cerebrovascular accident (Stroke), representing one of the leading causes of death in Spain and the rest of industrialized countries. This pathology has devastating aftermath and it is considered the foremost cause of permanent disability and the second cause of dementia. If we add the social cost (specialized caregivers, family dependence), it can be considered that stroke is one of the pathologies with greater impact on quality of life and on public health system.
With the aim to approach the development of new treatments for this disease, the consortium that comprises the project METABOLOPATIAS, of which Praxis Pharmaceutical is a partner, is in the process of being implemented and an attempt will be made to approach the:
- Development and patent of new compounds.
- Biochemical, morphological and physiological assays of those compounds to determine if they show a significant palliative effect in animal models of stroke and metabolic diseases that increase the risk of stroke.
- Development of analytical methods and basic galenic for the potential molecules to be used has drugs for these pathologies.
- Preclinical toxicology and pharmacokinetics assays.
- Development of analytical methods and basic galenic.

The project “Desarrollo farmacéutico de lípidos de diseño para el tratamiento del ICTUS y patologías relacionadas (METABOLOPATÍAS)”, RTC-2015-4094-1, has been financed by the Ministerio de Industria, Economía y Competitividad, through the Retos-Colaboración 2015 calling of the Programa Estatal de Investigación, Desarrollo e Innovación Orientada a los Retos de la Sociedad, from Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016.

 

Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continúa navegando, consideramos que acepta su uso. Puede obtener más información, o bien conocer cómo cambiar la configuración, en nuestro enlace Políticas de Seguridad. We use our own cookies and third-party cookies to improve our services and show related advertising to your preferences by analyzing their browsing habits. If you continue to browse, consider accepting its use. You can get more information, or how to change the settings in our Política de privacidad.